About Anastrozole Ip/bp/usp
Anastrozole Ip/bp/usp
Name- Anastrozole
Synonyms Tetramethyl-5-(1H-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile
Molecular Formula- C17H19N5
Molecular Weight 293.37
CAS NO. 120511-73-1
Appearance White Crystalline Powder
Purity NLT99.5%
Specification USP32
Packaging details:
| Packaging details: | 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
| Storage: | Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
| Shelf Life: | 5 years if sealed and store away from direct sun light. |
Key Features and Quality StandardsAnastrozole meets rigorous pharmaceutical standards, with purity exceeding 99.0% and strict adherence to IP, BP, and USP specifications. Offered in a stable powder form, it supports the development of high-quality oncology formulations, ensuring optimal efficacy and safety for end users.
Application in Oncology FormulationsThis API is primarily used in creating medication tailored for breast cancer treatment. Its anti-cancer (antineoplastic) function makes it an essential raw material in many pharmaceutical formulations where therapy customization and patient safety are paramount.
Packaging and StorageAvailable in 1kg, 5kg, and 10kg pack sizes, Anastrozole is suitable for industrial, export, or research use. For best results, the product should be stored in a cool environment to maintain stability throughout its 36-month shelf life.
FAQs of Anastrozole Ip/bp/usp:
Q: How is Anastrozole IP/BP/USP typically used in pharmaceutical applications?
A: Anastrozole is mainly used as an active pharmaceutical ingredient in formulations for breast cancer treatment. Its high purity and standardized quality make it suitable for creating oncology medications where precise dosing and consistent efficacy are crucial.
Q: What is the benefit of choosing a >99.0% pure Anastrozole for medicine manufacturing?
A: A purity level above 99.0% ensures minimal impurities in the final product, resulting in safer, more effective medications. This high purity is especially important for oncology treatments, where patient safety and pharmacological consistency are paramount.
Q: When should Anastrozole formulations be administered, and to whom are they suitable?
A: Anastrozole formulations should only be administered to adults as prescribed by a healthcare professional. The specific indication is for breast cancer treatment, and dosage must follow the guidelines provided by a medical expert.
Q: Where can Anastrozole IP/BP/USP be sourced from?
A: Anastrozole IP/BP/USP is exported, manufactured, and supplied from India, meeting international pharmaceutical standards. It is available in various quantities to meet the needs of formulation manufacturers, research organisations, or distributors.
Q: What is the recommended process for handling and storing Anastrozole powder?
A: Anastrozole should be handled in accordance with pharmaceutical guidelines, using appropriate protective equipment. For storage, it is recommended to keep the powder in a cool environment to preserve its quality and maintain its 36-month shelf life.
Q: What makes Anastrozole an important component in oncology medicine?
A: Anastrozoles anti-cancer (antineoplastic) mechanism inhibits estrogen production, which can help slow the growth of estrogen-dependent breast tumors, making it vital in contemporary breast cancer therapies.